与未服用过药物,患有重度抑郁症的患者的自杀念头相关的因素
Xueying Liu1, Yanan Liu2, Ying Gao2
1Tianjin Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, China; Shangdong Mental Health Center, Shangdong, China.
Journal of affective disorders
|March 22, 2025
概括
年龄较小,单身状态,严重抑郁和IL-6水平升高预测大抑郁症患者的自杀念头 (SI). 这些因素可以帮助识别IS更高风险的个体.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 免疫学 免疫学 免疫学
背景情况:
- 炎症和免疫激活与抑郁症有关.
- 在主要抑郁症 (MDD) 中,这些标志物在自杀念头 (SI) 中的特定作用需要进一步研究.
研究的目的:
- 为了比较具有和没有SI的MDD患者之间的炎症标志物.
- 利用多个指标开发一种用于识别MDD患者的SI的预测模型.
主要方法:
- 151名第一期,从未服用过药物的MDD患者使用贝克自杀意念量表 (中文版) 评估SI.
- 患者被分为有SI的MDD (n=91) 和没有SI的MDD (n=60).
- 测量了白蛋白-6 (IL-6),瘤亡因子-α (TNF-α),催化酶 (CAT) 和超氧化溶解酶 (SOD) 的血水平.
主要成果:
- 年龄,HAMD延迟因子得分和血IL-6度是MDD患者SI的显著预测因素.
- 结合年龄,婚姻状况,HAMD延迟因子得分和血IL-6的预测小组显示出良好的预测性能 (AUC = 0.812).
结论:
- 较年轻的年龄,单身婚姻状况,严重的延迟症状和较高的IL-6血度与MDD中IS易感性增加有关.
- 这些发现表明,潜在的生物标志物用于识别MDD患者有自杀想法风险.
相关概念视频
Depressive Disorders: Etiology
26
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
26
Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
Antidepressant Drugs: Overview
343
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
343
Psychological and Sociocultural Causes of Schizophrenia
41
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
41
Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32


